Fundraising Fox

Automated bioanalysis platform (Boston) Link

Boston, US · Founded 2024 · Delaware corporation · 4 known investors

dash.bio ↗
BiotechHealthtechin /dashbio

Founders & leadership

DJ
David JohnsonExecutive Officer, Director
AT
Alexander TallettExecutive Officer, Director
AS
Andy SmithDirector

Investors · 4

LifeX VenturesSan Franciscovia Inaki Berenguer · inferred
Oak HC/FTStamford
Swift VenturesSan Francisco
Freestyle CapitalreportedSan Rafael · $1.5M – $4M

Reported raises · per SEC filings

Form D private placements
▶$30MraisedJul 2026 · 9 investors · Other Health Care
Rule 506(b)
Dash Bio Raises $30M in Series A Funding to Develop Automated Bioanalysis Platform for Drug Discoverytheaiinsider.tech · Aug 2026Dash Bio raises $30M Series A to accelerate bioanalysis turnaround times | BioPharm Internationalbiopharminternational.com · Aug 2026
Officers, directors & promoters on the filing
  • David JohnsonExecutive Officer, Director
  • Alexander TallettExecutive Officer, Director
  • Andy SmithDirector
Offering amount
$30M
Amount sold
$30M
First sale
Jun 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11MraisedJun 2025 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ALEXANDER TALLETTExecutive Officer, Director
  • DAVID JOHNSONExecutive Officer, Director
Amount sold
$11M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedOct 2024 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DAVID JOHNSONExecutive Officer, Director
  • ALEXANDER TALLETTExecutive Officer, Director
Amount sold
$6.1M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news